Back to Journals » International Journal of Nanomedicine » Volume 12
RETRACTED ARTICLE: Aptamer-conjugated PEGylated quantum dots targeting epidermal growth factor receptor variant III for fluorescence imaging of glioma
Authors Tang J, Huang N, Zhang X, Zhou T, Tan Y, Pi J, Pi L, Cheng S, Zheng H 
, Cheng Y
Received 24 January 2017
Accepted for publication 18 April 2017
Published 22 May 2017 Volume 2017:12 Pages 3899—3911
DOI https://doi.org/10.2147/IJN.S133166
Checked for plagiarism Yes
Review by Single anonymous peer review
Peer reviewer comments 3
Editor who approved publication: Dr Linlin Sun
This paper has been retracted.
Tang J, Huang N, Zhang X, et al. Int J Nanomedicine. 2017;12:3899–3911. https://doi.org/10.2147/IJN.S133166
We, the Editors and Publisher of the Journal, International Journal of Nanomedicine have retracted the published article.
After publication, concerns have been raised by a third party in 2025 about the integrity of the data in Figure 3 of the article.
Further investigation conducted by the Journal and Publisher confirmed unusual similarities present in the image panels representative of different treatment conditions in Figure 3. Additional data integrity concerns were identified in Figures 6 and 7 due to unexpected similarities between image panels representative of different samples. When approached for an explanation, the authors have been unable to fully address the concerns raised.
As verifying the validity of published work is core to the integrity of the scholarly record, we are therefore retracting the article. The corresponding author listed in this publication has been informed.
We have been informed in our decision-making by our editorial policies and the COPE guidelines.
The retracted article will remain online to maintain the scholarly record, but it will be digitally watermarked on each page as ‘Retracted’.
© 2017 The Author(s). This work is published and licensed by Dove Medical Press Limited. The
full terms of this license are available at https://www.dovepress.com/terms
and incorporate the Creative Commons Attribution
- Non Commercial (unported, 3.0) License.
By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted
without any further permission from Dove Medical Press Limited, provided the work is properly
attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms.